Eli Lilly and Company (NYSE: LLY)
| Pre-Market | Intra-Day | After-Hours |
|---|---|---|
| 919.94 (16.51 / 1.83%) | 926.79 (22.80 / 2.52%) | 926.60 (-0.19 / -0.02%) |
| 17-Apr 09:20 | 17-Apr 15:59 | 17-Apr 19:00 |
Sector: Healthcare || Industry: Drug Manufacturers - General
| Previous Close | 903.99 | Year Low | 623.78 |
| Open | 917.80 | Year High | 1133.95 |
| Day Low | 917.80 | Price Avg 50 | 976.95 |
| Day High | 929.99 | Price Avg 200 | 904.61 |
| Volume | 2.43 M | Market Cap | 875.65 B |
News
Analysis
| Symbol | 1D | 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|---|---|
| LLY | 2.52 | -3.83 | -0.38 | -10.75 | 15.44 | 10.34 |
Earnings
| Date | Time | Symbol | company_name | Period | Metric | Estimate | Actual | Surprise | YrAgo | Growth | sector_industry |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/30/2026 | BMO | LLY | Eli Lilly | Q1 2026 | EPS | 7.69 | 3.34 | ||||
| 04/30/2026 | BMO | LLY | Eli Lilly | Q1 2026 | REV | 17.36 B | 0.00 | 12.73 B | 0.00 | ||
| 02/04/2026 | BMO | LLY | Eli Lilly and Co | Q4 2025 | EPS | 6.67 | 7.54 | 13.04 | 5.32 | 41.70 | |
| 02/04/2026 | BMO | LLY | Eli Lilly and Co | Q4 2025 | REV | 17.96 B | 19.30 B | 7.47 | 13.53 B | 42.65 | |
| 10/30/2025 | BMO | LLY | Eli Lilly | Q3 2025 | EPS | 5.70 | 7.02 | 23.16 | 1.18 | 494.90 | |
| 10/30/2025 | BMO | LLY | Eli Lilly | Q3 2025 | REV | 16.02 B | 17.60 B | 9.90 | 11.44 B | 53.87 | |
| 08/07/2025 | BMO | LLY | Eli Lilly | Q2 2025 | EPS | 6.07 | 6.31 | 3.95 | 3.92 | 61.00 | |
| 08/07/2025 | BMO | LLY | Eli Lilly | Q2 2025 | REV | 15.42 B | 15.56 B | 0.91 | 11.30 B | 37.64 | |
| 05/01/2025 | BMO | LLY | Eli Lilly | Q1 2025 | EPS | 3.02 | 3.34 | 10.60 | 2.58 | 29.50 | Healthcare / Drug Manufacturers—General |
| 05/01/2025 | BMO | LLY | Eli Lilly | Q1 2025 | REV | 12.67 B | 12.73 B | 0.49 | 8.77 B | 45.18 | Healthcare / Drug Manufacturers—General |
Outlooks
| Date | Time | Symbol | Company | Period | Metric | Estimate | Outlook | Previous | Catalyst | list_link | eps_est | rev_est | cur_midpoint | pre_midpoint | Growth * | yrago_growth | pre_growth | company_sector | company_industry | ref_id | chart_code | history_code | sector_industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/04/2026 | 06:45 AM | LLY | Eli Lilly and Co | FY 2026 | EPS | $33.23 | $33.50 ~ $35.00 | 0.00 | 34.25 | 3.07 | 43,113 | ||||||||||||
| 02/04/2026 | 06:45 AM | LLY | Eli Lilly and Co | FY 2026 | REV | $77.62 B | $80.00 B ~ $83.00 B | 0.00 | 81,500.00 | 5.00 | 43,113 |
Ratings
| Date | Symbol | Analyst Firm | Rating Current | Rating Previous | Analyst Action |
|---|---|---|---|---|---|
| 04/10/2026 | LLY | Morgan Stanley | Overweight | Overweight | Maintain |
| 04/02/2026 | LLY | B of A Securities | Buy | Buy | Maintain |
| 03/30/2026 | LLY | Guggenheim | Buy | Buy | Maintain |
| 03/17/2026 | LLY | HSBC | Reduce | Hold | Downgrade |
| 02/10/2026 | LLY | Freedom Broker | Buy | Hold | Upgrade |
| 02/09/2026 | LLY | Deutsche Bank | Buy | Buy | Maintain |
| 02/05/2026 | LLY | Wells Fargo | Overweight | Overweight | Maintain |
| 02/05/2026 | LLY | Cantor Fitzgerald | Overweight | Overweight | Maintain |
| 02/05/2026 | LLY | JP Morgan | Overweight | Overweight | Maintain |
| 02/05/2026 | LLY | Morgan Stanley | Overweight | Overweight | Maintain |
Dividends
| Date | Symbol | Company | Type | Value | Yield | Record Date | Exch Date | Pay Date | Notes |
|---|---|---|---|---|---|---|---|---|---|
| 12/08/2025 | LLY | Eli Lilly and Co | Quarterly | 1.73 | 0.01 | 02/13/2026 | 02/13/2026 | 03/10/2026 | Increased |
| 10/27/2025 | LLY | Eli Lilly | Quarterly | 1.50 | 0.01 | 11/14/2025 | 11/14/2025 | 12/10/2025 | Increased |
| 06/23/2025 | LLY | Eli Lilly | Quarterly | 1.50 | 0.01 | 08/15/2025 | 08/15/2025 | 09/10/2025 | Increased |
| 05/05/2025 | LLY | Eli Lilly | Quarterly | 1.50 | 0.01 | 05/16/2025 | 05/16/2025 | 06/10/2025 | Increased |
Sign-Up to see the full list of CATALYSTS in the Calendars